Aspirin 75mg dispersible tablets
Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Patient Information leaflet
(PIL)
30-11--0001
Summary of Product characteristics
(SPC)
24-04-2017
Public Assessment Report
(PAR)
10-02-2006
Active ingredient:
Aspirin
Available from:
Waymade Healthcare Plc
ATC code:
B01AC06
INN (International Name):
Aspirin
Dosage:
75mg
Pharmaceutical form:
Dispersible tablet
Administration route:
Oral
Class:
No Controlled Drug Status
Prescription type:
Valid as a prescribable product
Product summary:
BNF: 02090000
Patient Information leaflet
MPS READ DIRECTION
WOCKHARDT TRAVEL DIRECTION
Pharmacode:
Process Black
Keylines (non-printing)
Wockhardt UK Limited
ASPIRIN 75MG DISPERSIBLE TABS
103828/6
See uploaded pdf
300 x 128mm
ADA
2
21/03/2017
836625
N/A
9pt (Main Body) / 8pt (Variables)
UK
English
N/A
MEASURE BAR SHOULD BE 150MM AT 100% SCALE
Customer
Description
Item Code
Profile
Size
Min. Point Size
Market
Language
Proof By
Proof No.
Date
Artwork No.
Pharma
Code
Colours Used
WARNING! We cannot accept responsibility for any errors
in this proof after approval. Whilst we take extreme care
at all times to ensure accuracy to our clientʼs brief,
the final responsibility must be taken by our client.
IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING
FULL APPROVAL OF DESIGN AND TEXT.
artwork.leicester@CIRRUS-ARTWORK.com
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Always take this medicine exactly as described in
this leaflet or as your doctor, pharmacist or nurse
have told you.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more
information or advice
- If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. See section 4.
- You must talk to a doctor if you do not feel better
or if you feel worse.
The name of your medicine is Aspirin 75mg
Dispersible Tablets. In the rest of this leaflet, it is
called Aspirin Tablets.
WHAT IS IN THIS LEAFLET
1. What Aspirin Tablets are and what they are
used for
2. What you need to know before you take
Aspirin Tablets
3. How to take Aspirin Tablets
4. Possible side effects
5. How to store Aspirin Tablets
6. Contents of the pack and other information
1. WHAT ASPIRIN 75MG DISPERSIBLE TABLETS ARE
AND WHAT THEY ARE USED FOR
The active ingredient in your medicine is Aspirin.
Aspirin belongs to a group of medicines called
non-steroidal anti-inflammatory drugs (NSAIDs).
Aspirin thins the blood, which helps to reduce the
likelihood of having a
Read the complete document
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Aspirin 75mg Dispersible Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aspirin 75mg
Excipient with known effect
Lactose 0.0275g
For the full list of Excipients, see section 6.1
3
PHARMACEUTICAL FORM
Dispersible tablets.
White, flat tablets, embossed on one side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the secondary prevention of thrombotic cerebrovascular or
cardiovascular
disease and following by-pass surgery.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The advice of a doctor should be sought before commencing therapy for
the
first time.
The usual dosage, for long term use, is 75-150mg once daily. In some
circumstances a higher dose may be appropriate, especially in the
short term,
and up to 300 mg a day may be used on the advice of a doctor.
Do not give to children aged under 16 years, unless specifically
indicated (e.g.
for Kawasaki’s disease).
Method of administration
Oral
Tablets should be dissolved in water before being taken.
Gastro-intestinal irritation may be reduced by taking aspirin with or
immediately after food.
4.3
CONTRAINDICATIONS
•
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1. In patients with a history of hypersensitivity
to
aspirin (or any of the excipients) or any other NSAIDs and in patients
in
whom attacks of asthma, angioedema, urticaria or rhinitis have been
precipitated by aspirin or other NSAIDs.
•
Children under 16 years unless specifically indicated (e.g. for
Kawasaki’s disease)._ _
•
Active peptic ulceration or a history of peptic ulceration
•
Haemophilia,_ _other coagulopathies or concurrent anticoagulant
therapy._ _
•
Before commencing long-term aspirin therapy for the management of
cardiovascular or cerebrovascular disease patients should consult
their
doctor who can advise on the relative benefits of aspirin versus the
risks for the individual patient.
•
Gout
•
Doses > 100mg/day during the third trimester of pregnancy.
4.
Read the complete document
